Search Results Search Sort by RelevanceMost Recent State of the Art and Science Nov 2015 The Challenge of Understanding Health Care Costs and Charges Vineet Arora, MD, MAPP, Christopher Moriates, MD, and Neel Shah, MD, MPP The price transparency movement seeks to make actual medical costs clear to patients and clinicians. AMA J Ethics. 2015;17(11):1046-1052. doi: 10.1001/journalofethics.2015.17.11.stas1-1511. Case and Commentary Nov 2017 Should Health Care Organizations Use Information Gleaned from Organization-Sponsored Patient Support Groups in Strategic Planning? Priya Nambisan, PhD The risks of misinformation being spread through online patient forums can be mitigated by communication strategies aimed at physicians and organizations. AMA J Ethics. 2017;19(11):1088-1095. doi: 10.1001/journalofethics.2017.19.11.ecas3-1711. Medicine and Society Feb 2021 How Can the Experiences of Black Women Living With HIV Inform Equitable and Respectful Reproductive Health Care Delivery? Faith E. Fletcher, PhD, MA, Ndidiamaka Amutah-Onukagha, PhD, MPH, Julie Attys, MPH, and Whitney S. Rice, DrPH, MPH Black women living with HIV contend with injuries of injustice that influence their reproductive lives. AMA J Ethics. 2021;23(2):E156-165. doi: 10.1001/amajethics.2021.156. State of the Art and Science Nov 2017 How Should Organizations Promote Equitable Distribution of Benefits from Technological Innovation in Health Care? Satish Nambisan, PhD and Priya Nambisan, PhD Fair distribution demands new strategies for engaging patients in co-creation. AMA J Ethics. 2017;19(11):1106-1115. doi: 10.1001/journalofethics.2017.19.11.stas1-1711. State of the Art and Science Nov 2017 Why Aren’t Our Digital Solutions Working for Everyone? Brian Van Winkle, MBA, Neil Carpenter, MBA, and Mauro Moscucci, MD, MBA To fairly distribute the benefits of digital technologies, clinicians will need to be incentivized to adopt technologies that target the underserved. AMA J Ethics. 2017;19(11):1116-1124. doi: 10.1001/journalofethics.2017.19.11.stas2-1711. Case and Commentary Aug 2021 How Should Willingness-to-Pay Values of Quality-Adjusted Life-Years Be Updated and According to Whom? Paul T. Menzel, PhD Justification for using WTP values and QALYs lies in incorporating preferences of those whose treatment could be affected. AMA J Ethics. 2021;23(8):E601-606. doi: 10.1001/amajethics.2021.601. Case and Commentary Aug 2021 How Should Economic Value Be Considered in Treatment Decisions for Individual Patients? Hadley Stevens Smith, PhD, MPSA Physicians’ primary responsibility is to promote patients’ well-being, which includes not causing financial harm. AMA J Ethics. 2021;23(8):E607-612. doi: 10.1001/amajethics.2021.607. Medical Education Aug 2021 How Should Economic Evaluation Be Used to Measure Value and Set Priorities in Health Care? Sahan Jayawardana, MSc and Elias Mossialos, MD, PhD Novel interventions that are effective and safe but costly suggest the importance of questions about value, accessibility, and affordability. AMA J Ethics. 2021;23(8):E613-618. doi: 10.1001/amajethics.2021.613. In the Literature Aug 2021 “Perspectives” in Health Technology Assessment Anthony J. Culyer, DEcon Whether any particular perspective is the right one is contingent upon conditions in which the analysis is to be applied. AMA J Ethics. 2021;23(8):E619-623. doi: 10.1001/amajethics.2021.619. State of the Art and Science Aug 2021 How Economic Decision Modeling Can Facilitate Health Equity Jeffrey S. Hoch, PhD, Logan Trenaman, PhD, Shannon M. Hearney, MPH, and Carolyn S. Dewa, PhD, MPH Modeling how technology assessment fits into cost-effectiveness frameworks can broaden the range of options for improving health equity. AMA J Ethics. 2021;23(8):E624-630. doi: 10.1001/amajethics.2021.624. Pagination First page « First Previous page ‹ Previous … Page 2 Page 3 Page 4 Page 5 Current page 6 Page 7 Page 8 Page 9 Page 10 … Next page Next › Last page Last »
State of the Art and Science Nov 2015 The Challenge of Understanding Health Care Costs and Charges Vineet Arora, MD, MAPP, Christopher Moriates, MD, and Neel Shah, MD, MPP The price transparency movement seeks to make actual medical costs clear to patients and clinicians. AMA J Ethics. 2015;17(11):1046-1052. doi: 10.1001/journalofethics.2015.17.11.stas1-1511.
Case and Commentary Nov 2017 Should Health Care Organizations Use Information Gleaned from Organization-Sponsored Patient Support Groups in Strategic Planning? Priya Nambisan, PhD The risks of misinformation being spread through online patient forums can be mitigated by communication strategies aimed at physicians and organizations. AMA J Ethics. 2017;19(11):1088-1095. doi: 10.1001/journalofethics.2017.19.11.ecas3-1711.
Medicine and Society Feb 2021 How Can the Experiences of Black Women Living With HIV Inform Equitable and Respectful Reproductive Health Care Delivery? Faith E. Fletcher, PhD, MA, Ndidiamaka Amutah-Onukagha, PhD, MPH, Julie Attys, MPH, and Whitney S. Rice, DrPH, MPH Black women living with HIV contend with injuries of injustice that influence their reproductive lives. AMA J Ethics. 2021;23(2):E156-165. doi: 10.1001/amajethics.2021.156.
State of the Art and Science Nov 2017 How Should Organizations Promote Equitable Distribution of Benefits from Technological Innovation in Health Care? Satish Nambisan, PhD and Priya Nambisan, PhD Fair distribution demands new strategies for engaging patients in co-creation. AMA J Ethics. 2017;19(11):1106-1115. doi: 10.1001/journalofethics.2017.19.11.stas1-1711.
State of the Art and Science Nov 2017 Why Aren’t Our Digital Solutions Working for Everyone? Brian Van Winkle, MBA, Neil Carpenter, MBA, and Mauro Moscucci, MD, MBA To fairly distribute the benefits of digital technologies, clinicians will need to be incentivized to adopt technologies that target the underserved. AMA J Ethics. 2017;19(11):1116-1124. doi: 10.1001/journalofethics.2017.19.11.stas2-1711.
Case and Commentary Aug 2021 How Should Willingness-to-Pay Values of Quality-Adjusted Life-Years Be Updated and According to Whom? Paul T. Menzel, PhD Justification for using WTP values and QALYs lies in incorporating preferences of those whose treatment could be affected. AMA J Ethics. 2021;23(8):E601-606. doi: 10.1001/amajethics.2021.601.
Case and Commentary Aug 2021 How Should Economic Value Be Considered in Treatment Decisions for Individual Patients? Hadley Stevens Smith, PhD, MPSA Physicians’ primary responsibility is to promote patients’ well-being, which includes not causing financial harm. AMA J Ethics. 2021;23(8):E607-612. doi: 10.1001/amajethics.2021.607.
Medical Education Aug 2021 How Should Economic Evaluation Be Used to Measure Value and Set Priorities in Health Care? Sahan Jayawardana, MSc and Elias Mossialos, MD, PhD Novel interventions that are effective and safe but costly suggest the importance of questions about value, accessibility, and affordability. AMA J Ethics. 2021;23(8):E613-618. doi: 10.1001/amajethics.2021.613.
In the Literature Aug 2021 “Perspectives” in Health Technology Assessment Anthony J. Culyer, DEcon Whether any particular perspective is the right one is contingent upon conditions in which the analysis is to be applied. AMA J Ethics. 2021;23(8):E619-623. doi: 10.1001/amajethics.2021.619.
State of the Art and Science Aug 2021 How Economic Decision Modeling Can Facilitate Health Equity Jeffrey S. Hoch, PhD, Logan Trenaman, PhD, Shannon M. Hearney, MPH, and Carolyn S. Dewa, PhD, MPH Modeling how technology assessment fits into cost-effectiveness frameworks can broaden the range of options for improving health equity. AMA J Ethics. 2021;23(8):E624-630. doi: 10.1001/amajethics.2021.624.